Loading organizations...
Loading organizations...
Biopharmaceutical company developing curative treatments for chronic HBV.
Chromis Therapeutics has raised $3.0M across 1 funding round.
Chromis Therapeutics has raised $3.0M in total across 1 funding round.
Chromis Therapeutics has raised $3.0M in total across 1 funding round.
Chromis Therapeutics's investors include Torrey Pines Investment.
Chromis Therapeutics has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in February 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 26, 2016 | $3.0M Seed | Torrey Pines Investment |